BioSpace News Archive

Agile Therapeutics, Inc., a forward-thinking women’s healthcare company, announced it will report first quarter 2020 financial results after the market close on Tuesday, May 5, 2020.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced that the company will release financial results for the first quarter 2020, after the market close on Thursday, April 30, 2020.

Led cellular immunology at AgenTus and recognized expert on the biology and clinical application of Natural Killer T (NKT) cells and other immune cells

Menlo Therapeutics Inc. announced that its wholly-owned subsidiary, Foamix Pharmaceuticals Ltd., has entered into a licensing agreement with specialty pharmaceutical company Cutia Therapeutics Limited, an affiliate of Cutia Therapeutics for AMZEEQ™ topical foam, 4% as well as its other topical minocycline product candidates, once approved, on an exclusive basis in Greater China.

BeyondSpring Inc. announced that the Company will report its fourth-quarter and full-year 2019 financial results and host an operational update conference call on Thursday, April 30, 2020, at 8 a.m. Eastern Time..

Alimera Sciences, Inc. announces it received on April 22, 2020 approximately $1.8 million in support from the federal government under the Paycheck Protection Program.

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced registered direct offering of 722,502 American Depositary Shares (“ADSs”), each representing six hundred (600) of the Company’s ordinary shares, at a purchase price of $2.00 per ADS for gross proceeds of approximately $1.44 million. H.C. Wainwright &

Biotricity Inc., a medical diagnostic and consumer healthcare technology company, announced that its CEO, Waqaas Al-Siddiq, was recently interviewed on OAN to discuss Telemedicine and how Biotricity and its Bioflux solution can be used to expand the use cases for Telemedicine.

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular $1 million to enable the application of Integral Molecular’s technology platforms to aid in the discovery of vaccines and therapeutics to combat COVID-19.

Zymo Research Corp, a California-based life science reagent company and Opentrons Labworks, Inc, makers of affordable and easy-to-use lab robotics, have partnered to create a robust engine for SARS-CoV-2 molecular testing.